Please find information below on the invited Workshops that have been confirmed to-date for ANR2018. This information will be updated as the conference nears.

Immunotherapy Beyond GD2 for the oncologist: Role of T cells, NK cells, PD1 and the Microenvironment

Wednesday May 9, 2018, 1:00-3:00 PM

The immunotherapy workshop may include optimal preclinical models for immunotherapy, targeting the microenvironment, combination immunotherapies, cellular therapies with NK cells, CAR-T cells, vaccines, ongoing clinical trials, and toxicities.


Precision Medicine: Optimal Trial Design, Predictive Biomarkers, Efficacy 

Wednesday May 9, 2018, 3:30-5:30 PM

This workshop will examine and discuss challenges and best practices for effectively utilizing genetic information in the design and implementation of clinical trials to support the development of precision medicines, including exploring the potential advantages and disadvantages of such trials in neuroblastoma and across a variety of pediatric cancers.

RNA and PostTranslational Control: How Do We Identify Protein Drivers as Targets

Thursday, May 10, 2018, 1;00-3:00 PM

This workshop will explore the roles of altered mRNA translational regulation in cancer development, including how translation control influences adaptive responses to oncogenic stress, as well as pharmacological approaches to target the translation machinery in neuroblastoma.


New Biomarker Technologies: Prognostic or Descriptive?


Thursday May 10, 2018, 3:30-5:30 PM

This workshop will evaluate the data on circulating miRNA, circulating exosomes, ctDNA, RNA. An overview of new methods to evaluate tumor tissue with CYTOF, MIBI, RNA sequencing will also be provided. We will discuss whether these biomarkers reflect tumor biology, emerging subclones, or can be used for prediction of prognosis or as biomarkers of response.


Registration for ANR2018 opens this fall!